Multi-National Phase III Vitala™ 12-Hour Wear Test

Completed · Phase 3

Conditions studied: Colostomy

In brief

The purpose of this clinical study is to demonstrate that the Vitala™ Continence Control Device is both safe and effective when worn up to 12 hours per day.

Key facts

Study ID
NCT00902252
Run by
ConvaTec Inc.
People needed
78
Starts
2009-04-01
Expected to finish
2010-01-01
Last updated by the study team
2010-05-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.